139 related articles for article (PubMed ID: 124700)
41. Pain expression and stimulus localisation in individuals with Down's syndrome.
Hennequin M; Morin C; Feine JS
Lancet; 2000 Dec; 356(9245):1882-7. PubMed ID: 11130384
[TBL] [Abstract][Full Text] [Related]
42. Hyperthyrotropinaemia in untreated subjects with Down's syndrome aged 6 months to 64 years: a comparative analysis.
Meyerovitch J; Antebi F; Greenberg-Dotan S; Bar-Tal O; Hochberg Z
Arch Dis Child; 2012 Jul; 97(7):595-8. PubMed ID: 22535238
[TBL] [Abstract][Full Text] [Related]
43. Australia antigen and Down's syndrome.
Shapiro LR; Redner WJ; Innella FP
Lancet; 1971 Jul; 2(7717):215-6. PubMed ID: 4104877
[No Abstract] [Full Text] [Related]
44. Palpebral syringomas and Down's syndrome.
Schepis C; Siragusa M; Palazzo R; Ragusa RM; Massi G; Fabrizi G
Dermatology; 1994; 189(3):248-50. PubMed ID: 7949476
[TBL] [Abstract][Full Text] [Related]
45. Leucocyte migration in presence of leukaemia-associated antigens in children with Down's syndrome.
Szigeti R; Révész T; Schuler D; Gerö-Ferencz E; Zsuráffy E
Haematologia (Budap); 1976; 10(1):23-6. PubMed ID: 137841
[TBL] [Abstract][Full Text] [Related]
46. Immunodeficiency in Down's syndrome. Titres of "natural" antibodies to E. coli and rabbit erythrocytes at different ages.
Ugazio AG; Lanzavecchia A; Jayakar S; Plebani A; Duse M; Burgio GR
Acta Paediatr Scand; 1978 Nov; 67(6):705-8. PubMed ID: 152559
[TBL] [Abstract][Full Text] [Related]
47. Down's syndrome, interferon sensitivity and the development of leukaemia.
Zihni L
Leuk Res; 1994 Jan; 18(1):1-6. PubMed ID: 8289462
[TBL] [Abstract][Full Text] [Related]
48. Detection of Lewy bodies in Trisomy 21 (Down's syndrome).
Raghavan R; Khin-Nu C; Brown A; Irving D; Ince PG; Day K; Tyrer SP; Perry RH
Can J Neurol Sci; 1993 Feb; 20(1):48-51. PubMed ID: 8467429
[TBL] [Abstract][Full Text] [Related]
49. Clinical diagnosis of Down's syndrome.
Jackson JF; North ER; Thomas JG
Clin Genet; 1976 May; 9(5):483-7. PubMed ID: 131663
[TBL] [Abstract][Full Text] [Related]
50. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
51. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
Khoshnood B; Pryde P; Blondel B; Lee KS
Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
[TBL] [Abstract][Full Text] [Related]
52. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
[TBL] [Abstract][Full Text] [Related]
53. [Antigen of hepatitis B in Down's syndrome].
Moura Rde A; Schmidt BJ; Diament AJ; Krynski S
Arq Neuropsiquiatr; 1974 Dec; 32(4):310-3. PubMed ID: 4280296
[No Abstract] [Full Text] [Related]
54. Immunologic dysfunction: simultaneous study of Alzheimer's and older Down's patients.
Singh VK; Fudenberg HH; Brown FR
Mech Ageing Dev; 1986-1987 Jan; 37(3):257-64. PubMed ID: 2952844
[TBL] [Abstract][Full Text] [Related]
55. Sequence of eruption of deciduous dentition in a Chilean sample with Down's syndrome.
Ondarza A; Jara L; Muñoz P; Blanco R
Arch Oral Biol; 1997 May; 42(5):401-6. PubMed ID: 9233850
[TBL] [Abstract][Full Text] [Related]
56. Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.
Schapiro MB; Haxby JV; Grady CL; Duara R; Schlageter NL; White B; Moore A; Sundaram M; Larson SM; Rapoport SI
J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):766-74. PubMed ID: 2956363
[TBL] [Abstract][Full Text] [Related]
57. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
58. Comparison of mental development in individuals with mosaic and trisomy 21 Down's syndrome.
Fishler K; Koch R; Donnell GN
Pediatrics; 1976 Nov; 58(5):744-8. PubMed ID: 135957
[TBL] [Abstract][Full Text] [Related]
59. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
[TBL] [Abstract][Full Text] [Related]
60. Neuroanatomy of Down's syndrome: a high-resolution MRI study.
Pinter JD; Eliez S; Schmitt JE; Capone GT; Reiss AL
Am J Psychiatry; 2001 Oct; 158(10):1659-65. PubMed ID: 11578999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
